日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Efficacy and safety of secondary induction radiotherapy in locally advanced resectable esophageal squamous cell carcinoma with poor responses to neoadjuvant immunochemotherapy: a retrospective study

新辅助免疫化疗反应不佳的局部晚期可切除食管鳞状细胞癌二次诱导放疗的疗效和安全性:一项回顾性研究

Lv, Huilai; Zhang, Ping; Dai, Liang; Ding, Weilu; Xie, Songping; Jiang, Hongjing; Duan, Xiaofeng; Chen, Ke-Neng; Tian, Ziqiang

A Subgroup Analysis of Perioperative Pembrolizumab in Clinical Stage II Non-Small-Cell Lung Cancer from the Randomized KEYNOTE-671 Study

来自 KEYNOTE-671 随机研究的围手术期帕博利珠单抗治疗 II 期非小细胞肺癌的亚组分析

Tsuboi, Masahiro; Wakelee, Heather; Garassino, Marina C; Gao, Shugeng; Luft, Alexander; Chen, Ke-Neng; Spicer, Jonathan D; Zhu, Yuming; Saji, Hisashi; Okada, Morihito; Vanakesa, Tõnu; Chen, Haiquan; Zhao, Guofang; Ikeda, Norihiko; Jones, David R; Weksler, Benny; Huang, Chien-Sheng; Jensen, Erin; Keller, Steven M; Samkari, Ayman; Liberman, Moishe

Neoadjuvant Nivolumab Plus Ipilimumab Versus Chemotherapy in Resectable Lung Cancer

可切除肺癌新辅助治疗中,纳武利尤单抗联合伊匹木单抗与化疗的比较

Awad, Mark M; Forde, Patrick M; Girard, Nicolas; Spicer, Jonathan; Wang, Changli; Lu, Shun; Mitsudomi, Tetsuya; Felip, Enriqueta; Broderick, Stephen R; Swanson, Scott J; Brahmer, Julie; Kerr, Keith; Saylors, Gene B; Chen, Ke-Neng; Gharpure, Vishwanath; Neely, Jaclyn; Balli, David; Hu, Nan; Provencio Pulla, Mariano

Neoadjuvant Osimertinib for Resectable EGFR-Mutated Non-Small Cell Lung Cancer

奥希替尼新辅助治疗可切除的EGFR突变型非小细胞肺癌

He, Jianxing; Tsuboi, Masahiro; Weder, Walter; Chen, Ke-Neng; Hochmair, Maximilian J; Shih, Jin-Yuan; Lee, Sung Yong; Lee, Kang-Yun; Nhung, Nguyen Viet; Saeteng, Somcharoen; Liu, Lunxu; Xing, Ligang; Gia, Nguyen Hoang; Murakami, Shuji; Han, Yongtao; Saavedra, María Paz; Yoon, Seong Hoon; Teixeira, Carlos H A; Escriu, Carles; Martinez-Marti, Alex; Blakely, Collin M; Yatabe, Yasushi; Dacic, Sanja; Rukazenkov, Yuri; Huang, Xiangning; Dayal, Anupriya; Chaft, Jamie E

Comparative efficacy of epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) monotherapy versus combined EGFR-TKI and chemotherapy in resectable EGFR-mutant non-small cell lung cancer: a real-world multicenter retrospective study

表皮生长因子受体酪氨酸激酶抑制剂(EGFR-TKI)单药治疗与EGFR-TKI联合化疗治疗可切除EGFR突变型非小细胞肺癌的疗效比较:一项真实世界多中心回顾性研究

Fan, Mengying; Zhao, Zerui; Yan, Wanpu; Fu, Hao; Huang, Shijie; Zhuo, Minglei; Yu, Rong; Yang, Xin; Qi, Liping; Liang, Zhen; Xiong, Hongchao; Xie, Jinbiao; Long, Hao; Chen, Ke-Neng

Establishment of a Chinese library of patient-derived xenografts from gastrointestinal cancers

建立中国胃肠道肿瘤患者来源异种移植瘤库

Liu, Ying; He, Wei; Wu, Qi; Ji, Jia-Fu; Shen, Lin; Hao, Chun-Yi; Xu, Rui-Ping; Chen, Ke-Neng; Wu, Nan; Cao, Chang-Qi; Hu, Ying; Zhang, Li-Xin; Chen, Huan-Yu; Hu, Zhe; Pan, Ya-Qi; Yuan, Wen-Qing; Li, Jing-Jing; Dong, Bin; Liu, Meng-Fei; Liu, Zhen; Liu, Fang-Fang; Cai, Hong; He, Zhong-Hu; Ke, Yang

Assessing response in endoscopy images of esophageal cancer treated with total neoadjuvant therapy via hybrid-architecture ensemble deep learning

利用混合架构集成深度学习评估接受新辅助治疗的食管癌患者内镜图像的反应

Yuan, Peng; Liu, Meichen; He, Hangzhou; Dai, Liang; Wu, Ya-Ya; Chen, Ke-Neng; Wu, Qi; Lu, Yanye

Prognosis and relapse patterns in patients with non-small cell lung cancer with pathologic complete response after neoadjuvant immunochemotherapy

新辅助免疫化疗后病理完全缓解的非小细胞肺癌患者的预后和复发模式

Fang, Yifan; Yan, Wanpu; Zhao, Ze-Rui; Jiang, Long; Yu, Xiangyang; Yang, Xin; Yu, Zhentao; Luo, Qingquan; Long, Hao; Chen, Ke-Neng

Effects of nutritional support during neoadjuvant therapy on perioperative outcome in esophageal cancer: a real-world cohort study

新辅助治疗期间营养支持对食管癌围手术期结局的影响:一项真实世界队列研究

Yang, Yongbo; He, Yan; Wei, Wan; Wu, Yaya; Chen, Hong; Gao, Yimei; Yan, Wanpu; Fan, Mengying; Ma, Shaohua; Liang, Zhen; Xiong, Hongchao; Dai, Liang; Chen, Ke-Neng

Neoadjuvant pembrolizumab plus chemotherapy followed by adjuvant pembrolizumab compared with neoadjuvant chemotherapy alone in patients with early-stage non-small-cell lung cancer (KEYNOTE-671): a randomised, double-blind, placebo-controlled, phase 3 trial

一项随机、双盲、安慰剂对照的3期临床试验(KEYNOTE-671):比较新辅助帕博利珠单抗联合化疗后序贯辅助帕博利珠单抗治疗与单纯新辅助化疗治疗早期非小细胞肺癌患者的疗效。

Spicer, Jonathan D; Garassino, Marina C; Wakelee, Heather; Liberman, Moishe; Kato, Terufumi; Tsuboi, Masahiro; Lee, Se-Hoon; Chen, Ke-Neng; Dooms, Christophe; Majem, Margarita; Eigendorff, Ekkehard; Martinengo, Gastón L; Bylicki, Olivier; Rodríguez-Abreu, Delvys; Chaft, Jamie E; Novello, Silvia; Yang, Jing; Arunachalam, Ashwini; Keller, Steven M; Samkari, Ayman; Gao, Shugeng